| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |